EDISON values SYGNIS at 37.5 million euros
12-Jul-2013
- Germany
In order to undertake the analysis of the share value of SYGNIS, EDISON focused on the predicted income of three products: QualiPhi, PrimPol and Double Switch. Meanwhile, EDISON have not considered any additional products the company has been developing (DNA repair kit).
Most read news
Organizations
Expedeon
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.